Langar Global HealthTech ETF
LGHT
5 hedge funds and large institutions have $2.37M invested in Langar Global HealthTech ETF in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
29.83% more ownership
Funds ownership: 90.96% → 120.79% (+30%)
28% more capital invested
Capital invested by funds: $1.85M → $2.37M (+$516K)
25% more funds holding
Funds holding: 4 → 5 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
I
INVST
Indianapolis,
Indiana
|
+$367K |
| 2 |
BWP
Balboa Wealth Partners
Scottsdale,
Arizona
|
+$159K |
| 3 |
MML Investors Services
Springfield,
Massachusetts
|
+$107K |
| 4 |
CWM
CarsonAllaria Wealth Management
Glen Carbon,
Illinois
|
+$158 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.15K |
LGHT Hedge Fund Activity: Q1 2025 in Review
5 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Langar Global HealthTech ETF (LGHT) for Q1 2025, worth a combined $2.37M — up 28% from $1.85M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new LGHT positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was INVST, adding an estimated $367K. The largest seller was UBS Group, exiting entirely with an estimated $2.15K sold.
- 5 institutional investors held Langar Global HealthTech ETF (LGHT) as of Q1 2025, up from 4 in Q4 2024.
- Funds reported $2.37M of Langar Global HealthTech ETF stock for Q1 2025, up 28% quarter-over-quarter.
- 2 funds opened new Langar Global HealthTech ETF positions in Q1 2025 and 1 closed out, a net change of +1 holder.
- The largest Langar Global HealthTech ETF buyer in Q1 2025 was INVST, an estimated $367K added.
- The largest Langar Global HealthTech ETF seller in Q1 2025 was UBS Group, an estimated $2.15K sold.
Based on aggregated 13F filings for Q1 2025.